Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Clinical and Translational Science
|
April 1, 2018
Can Graphics Tell Lies? A Tutorial on How To Visualize Your Data
Christopher Cabanski, Houston Gilbert, Sofia Mosesova
Bioanalysis
|
September 14, 2016
Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosis
Cheryl Schofield, Saloumeh K Fischer, Michael J Townsend, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 9, 2013
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study
Nicola A Hanania, Sally Wenzel, Karin Rosén, et al.
The Journal of Allergy and Clinical Immunology
|
June 4, 2013
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
Michael Noonan, Phillip Korenblat, Sofia Mosesova, et al.
The American Journal of Cardiology
|
March 28, 2017
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Amos Baruch, Sofia Mosesova, John D Davis, et al.
Clinical Pharmacology and Therapeutics
|
August 23, 2019
DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers
Hendrika W Grievink, Jules A A C Heuberger, Fen Huang, et al.
The New England Journal of Medicine
|
August 5, 2011
Lebrikizumab treatment in adults with asthma
Jonathan Corren, Robert F Lemanske, Nicola A Hanania, et al.
The Journal of Allergy and Clinical Immunology
|
August 4, 2012
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Guiquan Jia, Richard W Erickson, David F Choy, et al.
Trials
|
January 6, 2018
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial
Catherine E Hanratty, John G Matthews, Joseph R Arron, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Clinical and Translational Science
|
April 1, 2018
Can Graphics Tell Lies? A Tutorial on How To Visualize Your Data
Christopher Cabanski, Houston Gilbert, Sofia Mosesova
Bioanalysis
|
September 14, 2016
Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosis
Cheryl Schofield, Saloumeh K Fischer, Michael J Townsend, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 9, 2013
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study
Nicola A Hanania, Sally Wenzel, Karin Rosén, et al.
The Journal of Allergy and Clinical Immunology
|
June 4, 2013
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
Michael Noonan, Phillip Korenblat, Sofia Mosesova, et al.
The American Journal of Cardiology
|
March 28, 2017
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Amos Baruch, Sofia Mosesova, John D Davis, et al.
Clinical Pharmacology and Therapeutics
|
August 23, 2019
DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers
Hendrika W Grievink, Jules A A C Heuberger, Fen Huang, et al.
The New England Journal of Medicine
|
August 5, 2011
Lebrikizumab treatment in adults with asthma
Jonathan Corren, Robert F Lemanske, Nicola A Hanania, et al.
The Journal of Allergy and Clinical Immunology
|
August 4, 2012
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Guiquan Jia, Richard W Erickson, David F Choy, et al.
Trials
|
January 6, 2018
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial
Catherine E Hanratty, John G Matthews, Joseph R Arron, et al.
Page
of 1